NIH grant supports focused research projects requiring at least one clinical trial, aligning with the scientific interests of participating NIH Institutes and Centers.
Funder: National Institutes of Health
Due Dates: February 5, 2027 (New) | March 5, 2027 (Renewal/resubmission/revision) | June 5, 2027 (New) | July 5, 2027 (Renewal/resubmission/revision) | October 5, 2027 (New) | November 5, 2027 (Renewal/resubmission/revision) | January 7, 2028 (Closing date)
Funding Amounts: No budget cap; requests must reflect project needs; maximum project period of 5 years
Summary: Supports discrete, investigator-directed research projects proposing at least one clinical trial aligned with participating NIH Institutes and Centers.
Key Information: Some participating Institutes and Centers accept only mechanistic trials; foreign subawards/subcontracts are not allowed.
The NIH Parent R01 supports discrete, specified research projects within investigators’ interests and competencies and the scientific missions of participating NIH Institutes and Centers (ICs). Every application must propose at least one NIH-defined clinical trial: a study prospectively assigning human participants to interventions to evaluate health-related biomedical or behavioral outcomes.
Supported research includes safety and efficacy trials, mechanistic exploratory studies, and biomarker studies meeting the clinical trial definition. Mechanistic studies examine biological or behavioral processes, disease pathophysiology, or how interventions work, including research involving healthy participants. Some ICs accept only mechanistic trials through this announcement. Applicants are encouraged to discuss scientific fit with relevant IC staff before submitting; nonparticipating ICs will not consider applications for funding.